- Home
- GT vs ICUI Comparison
GT vs ICUI Comparison
Compare GT & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GT
- ICUI
- Stock Information
- Founded
- GT 1898
- ICUI 1984
- Country
- GT United States
- ICUI United States
- Employees
- GT N/A
- ICUI N/A
- Industry
- GT Automotive Aftermarket
- ICUI Medical/Dental Instruments
- Sector
- GT Consumer Discretionary
- ICUI Health Care
- Exchange
- GT Nasdaq
- ICUI Nasdaq
- Market Cap
- GT 3.2B
- ICUI 3.4B
- IPO Year
- GT N/A
- ICUI 1992
- Fundamental
- Price
- GT $11.20
- ICUI $130.54
- Analyst Decision
- GT Buy
- ICUI Strong Buy
- Analyst Count
- GT 3
- ICUI 5
- Target Price
- GT $14.67
- ICUI $196.75
- AVG Volume (30 Days)
- GT 6.2M
- ICUI 283.6K
- Earning Date
- GT 05-07-2025
- ICUI 05-08-2025
- Dividend Yield
- GT N/A
- ICUI N/A
- EPS Growth
- GT N/A
- ICUI N/A
- EPS
- GT 0.84
- ICUI N/A
- Revenue
- GT $18,594,000,000.00
- ICUI $2,420,093,000.00
- Revenue This Year
- GT $0.10
- ICUI N/A
- Revenue Next Year
- GT $1.14
- ICUI N/A
- P/E Ratio
- GT $13.33
- ICUI N/A
- Revenue Growth
- GT N/A
- ICUI 7.22
- 52 Week Low
- GT $7.27
- ICUI $101.44
- 52 Week High
- GT $12.58
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- GT 55.37
- ICUI 43.59
- Support Level
- GT $10.38
- ICUI $127.91
- Resistance Level
- GT $11.69
- ICUI $135.62
- Average True Range (ATR)
- GT 0.39
- ICUI 4.38
- MACD
- GT -0.01
- ICUI -0.30
- Stochastic Oscillator
- GT 62.60
- ICUI 14.73
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.